Xin-Jie Chu Email & Phone Number

Xin-Jie Chu Email & Phone Number

Chief Scientific Officer @ Hepagene Therapeutics

Arrow

5 free lookups per month.
No credit card required.

Arrow

Xin-Jie Chu's Location

Suzhou, CN

Xin-Jie Chu's Work

  • Director, External Medicinal Chemistry @ Merck
  • Principal Scientist and Senior Principal Scientist @ Roche
  • Postdoctoral Fellow in K.C. Nicolaou Group @ Scripps Research

Xin-Jie Chu's Education

  • Scripps Research

    1995 - 1997
  • 1988 - 1994

Xin-Jie Chu's Skills

  • Medicinal Chemistry
  • Drug Design
  • Drug Discovery
  • Organic Chemistry
  • Small Molecules

Xin-Jie Chu's Summary

Xin-Jie Chu, based in Suzhou, CN, is currently a Chief Scientific Officer at Hepagene Therapeutics, bringing experience from previous roles at Global Health Drug Discovery Institute, Merck and Hoffmann-La Roche. Xin-Jie Chu holds a 1995 - 1997 Scripps Research. With a robust skill set that includes Medicinal Chemistry, Drug Design, Drug Discovery, Organic Chemistry, Small Molecules and more, Xin-Jie Chu contributes valuable insights to the industry. Xin-Jie Chu has 3 emails and 1 mobile phone number on RocketReach.
Arrow

5 free lookups per month.
No credit card required.

If you need more lookups, subscriptions start at $48 USD/month.

Redirecting you to the search page.

If you're not automatically redirected, please click here

Not the Xin-Jie Chu you were looking for?

Find contact details for 700 million professionals.

People Like Xin-Jie Chu

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users